Benzyl urea derivatives for activating TGF-beta signaling
US9796674B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Inventors
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Oct 24, 2017 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/452
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treatment and prevention of disorders and conditions characterized by reduced TGF-B signaling are described. In particular, the compositions and methods are useful for reducing or eliminating the pathologies associated with Alzheimer's disease. The compositions include urea derivatives containing a piperidine, piperidinium, or a piperidin-4-yl methyl; cycloalkyl, aryl, and fluorobenzyl moieties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.